Evaluation of a vancomycin dosing protocol for intensive care unit patients

Area of Science:

• Pharmacology and Critical Care Medicine
• Antibiotic Stewardship
• Clinical Pharmacy Practice

Background:

• Vancomycin, a critical glycopeptide antibiotic, requires precise dosing to achieve therapeutic trough levels (15-20 mg/l).
• Optimizing vancomycin dosing in intensive care unit (ICU) patients presents significant clinical challenges.
• A collaborative ICU-pharmacy dosing protocol was implemented at Medical Center Leeuwarden to address these challenges.

Discussion:

• The study retrospectively analyzed data from 59 ICU patients to evaluate the protocol's effectiveness.
• Pharmacy involvement alongside the dosing protocol significantly improved the achievement of timely, adequate vancomycin trough levels (p = 0.016).
• Implementing the protocol without pharmacy collaboration showed non-significant improvements in early accurate trough levels.

Key Insights:

• Integrated pharmacy services and standardized dosing protocols are effective in optimizing vancomycin therapy in ICUs.
• The collaborative approach led to statistically significant improvements in achieving target vancomycin concentrations.
• The protocol's efficacy may be compromised in patients with unreliable estimated glomerular filtration rate (eGFR) measurements.

Outlook:

• Further research should focus on refining protocols for specific patient populations, including those with renal impairment.
• Careful and phased introduction of such protocols is essential for successful clinical implementation.
• This study highlights the value of interdisciplinary collaboration in enhancing antibiotic pharmacodynamics and patient outcomes.